Images in Haematology
Diagnosis of familial amyloidotic polyneuropathy by bone marrow biopsy
Kit-Fai Wong, Sidney Tam and Yok-Lam Kwong
p. 517–517
Post-transplant lymphoproliferative disorder of plasmacytoma-like subtype
Christina Kahl, Antonio Martinez and Stephan Moll
p. 518–518
Reviews
Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients
Penelope D. Barnes and Kieren A. Marr
p. 519–531
Progress in understanding and managing natural killer-cell malignancies
Kazuo Oshimi
p. 532–544
Haematological Malignancy
The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey
Jennifer Voke, Jane Keidan, Sue Pavord, Neil H. Spencer and Beverley J. Hunt on behalf of the British Society for Haematology Obstetric Haematology Group
p. 545–558
Proteomic evaluation of pathways associated with dexamethasone-mediated apoptosis and resistance in multiple myeloma
Karen S. Rees-Unwin, Rachel A. Craven, Emma Davenport, Sarah Hanrahan, Nicholas F. Totty, Ann M. Dring, Rosamonde E. Banks, Gareth J.Morgan and Faith E. Davies
p. 559–567
TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2
Alessandro Natoni, Marion MacFarlane, Satoshi Inoue, Renata Walewska, Aneela Majid, Deborah Knee, David R. Stover, Martin J. S. Dyer and Gerald M. Cohen
p. 568–577
Gene expression profiling of CD34+ cells in patients with the 5q− syndrome
Jacqueline Boultwood, Andrea Pellagatti, Helen Cattan, Charles H. Lawrie, Aristoteles Giagounidis, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Sally Killick, Carrie Fidler, Mario Cazzola, Eva Hellström-Lindberg and James S. Wainscoat
p. 578–589
High activity 90Y-ibritumomab tiuxetan (Zevalin®) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas
Pier F. Ferrucci, Anna Vanazzi, Chiara M. Grana, Marta Cremonesi, Mirco Bartolomei, Marco Chinol, Mahila Ferrari, Davide Radice, Stefano Papi, Giovanni Martinelli and Giovanni Paganelli
p. 590–599
B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle
Fiona Bennett, Andy Rawstron, Marieth Plummer, Ruth de Tute, Paul Moreton, Andrew Jack and Peter Hillmen
p. 600–604
Platelets, Haemostasis and Thrombosis
CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura
Shuguang Li, Lin Wang, Chunhong Zhao, Lizhen Li, Jun Peng and Ming Hou
p. 605–611
Red cells and Iron
Phase I study of eptifibatide in patients with sickle cell anaemia
Sheritha P. Lee, Kenneth I. Ataga, Mohamed Zayed, Jeanne M. Manganello, Eugene P. Orringer, David R. Phillips and Leslie V. Parise
p. 612–620
Correspondence
Use of intrapleural bortezomib in myelomatous pleural effusion
Emilio Iannitto, Viviana Minardi and Claudio Tripodo
p. 621–622
Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy
George Garratty and Lawrence D. Petz
p. 622–623
Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis
Emmanuel J. Favaloro, David Patterson, Anna Denholm, Scott Mead, Ann Gilbert, Anne Collins, Jane Estell, Peter M. George and Mark P. Smith
p. 623–626
Survey of members of myeloma UK on biphosphonates-associated jaw osteonecrosis
Kate Barker, Derek Lowe, Ade Olujohungbe, Eric Low and Simon N. Rogers
p. 626–628 |
